All Study Flyer
Click here to search for a research study.
Research that Makes a Difference
The UC Davis MIND Institute supports critical research designed to understand the causes and to develop effective diagnoses, treatments, preventions, and ultimately, cures for neurodevelopmental disorders. Advances in neuroscience, molecular biology, genetics, pharmacology and behavioral sciences are making inroads into understanding brain function. The MIND Institute draws from these and other disciplines to conduct collaborative multidisciplinary research on specific neurodevelopmental disorders, including autism Spectrum Disorders, Down Syndrome, Fragile X Syndrome, Attention-Deficit/Hyperactivity Disorder (ADHD) and Chromosome 22q11.2 Deletion Syndrome.
The MIND Institute is uniquely positioned to take advantage of the outstanding expertise at UC Davis. The university offers robust programs in biological, environmental, medical and toxicological sciences.
The scope and impact of the Institute’s Research Program is exceptional. Studies ranging from basic biological studies to treatment trials, have lead to important contributions in such areas as synapse formation and plasticity, biomarkers research, evaluating startle responses, mouse model for autism, gene therapy of the brain, functions of the fragile X and MeCP2 genes, brain structure and the epidemiology of autism.
Highlighted Study of the Month
A Controlled Trial of Sertraline in Young Children with ASD (SERT2)
The purpose of this study is to understand the effects of sertraline (Zoloft) on language development and autism symptoms in young children with Autism Spectrum Disorder (ASD).
- Who can participate: Children with ASD, ages 2-5 years 8 months old
- Number of Visits: 3
- What to expect: Three visits to the MIND Institute over six months (an initial visit, a three month visit, and a final six month visit). All visits will include a medical check. The initial and final visit will also include several assessments of language, development, and behaviors. The study medication is in liquid form and would need to be given once per day. There are also phone calls during the six months to see how your child is doing in the study.
- Compensation: No
Study Coordinator: Aisha Lott, 916-703-0472